On demand · Roundtable · Sponsored by Galderma
Trifarotene: Targeted RAR-γ Action in Acne & Acne Sequelae
A roundtable discussion on the latest clinical insights in acne management.
About this roundtable
What you'll learn
World-renowned dermatologists discuss the latest clinical insights on acne management, focused on trifarotene, a novel, potent retinoid: its unique mechanism of targeting skin receptors, its role in reducing new lesions, and outcomes for acne scars and persistent hyperpigmentation. Originally presented on September 5, 2025.
- How trifarotene’s targeted RAR-γ activity sets it apart from other retinoids.
- Its role in reducing new acne lesions.
- Clinical insights on acne sequelae, including acne scars and persistent hyperpigmentation.
Moderator & panelists
Ted Lain, MD, MBA
Moderator · Board-Certified Dermatologist · Co-Founder, The Science of Skin Summit
James Q. Del Rosso, DO
Board-Certified Dermatologist · Las Vegas, NV
Julie C. Harper, MD
Board-Certified Dermatologist · Birmingham, AL
Hilary E. Baldwin, MD
Board-Certified Dermatologist · New Brunswick, NJ
Keep watching
More webinars
New GLP-1 and Clinical Data Insights Integrated with Procedure
The advanced glycation science behind A.G.E. Interrupter Ultra Serum.
Watch now →